PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CHU de Bordeaux, Service de médecine interne et maladies infectieuses, Hôpital Saint-André, F-33000 Bordeaux, France.\', \'Univ. Bordeaux, F-33000 Bordeaux, France.\', \'IHU LIRYC, Université de Bordeaux, CHU de Bordeaux, Service de cardiologie, Hôpital Haut-Lévêque, F-33000 Bordeaux, France.\', \'CHU de Bordeaux, Service de pharmacie clinique des médicaments, Hôpital Saint-André, F-33000 Bordeaux, France.\', \'CHU de Bordeaux, Laboratoire de pharmacologie - toxicologie, Hôpital Pellegrin, F-33000 Bordeaux, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkaa441
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33221868
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all